Noticias de RCKT_US

Noticias del mercado

Últimas noticias sobre RCKT_US — 139 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: RCKT_US ✕ 139 resultados
01/04/2026 RCKT_US — MarketBeat
Rocket Pharmaceuticals, Inc. $RCKT Shares Acquired by JPMorgan Chase & Co.
31/03/2026 RCKT_US — MSN
RCKT stock dives despite gene therapy approval — Wall Street dismisses sell-off
30/03/2026 RCKT_US — The Globe and Mail
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
30/03/2026 RCKT_US — Benzinga
Expedia To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Monday
30/03/2026 RCKT_US — Zacks Investment Research
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
30/03/2026 RCKT_US — timothysykes.com
Rocket Pharmaceuticals Files $400M Mixed Shelf Offering, Opens Financing Doors
30/03/2026 RCKT_US — The Globe and Mail
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
30/03/2026 RCKT_US — Yahoo Finance
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
30/03/2026 RCKT_US — GuruFocus
RCKT: B of A Securities Raises Price Target on Buy Rating | RCKT Stock News
30/03/2026 RCKT_US — Bitget ES ← EN
Las acciones de RCKT caen incluso después de que la FDA aprueba la terapia genética para enfermedades poco comunes
30/03/2026 RCKT_US — TradingView
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
29/03/2026 RCKT_US — Yahoo Finance
Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI
29/03/2026 RCKT_US — Seeking Alpha
Rocket Pharmaceuticals: Kresladi Approval Validates Platform, But Commercial Upside Remains Limited
28/03/2026 RCKT_US — MSN
Rocket Pharma wins FDA nod for gene therapy (update)
28/03/2026 RCKT_US — timothysykes.com
Rocket Pharmaceuticals Delivers Bold Moves Amid Volatile Market
28/03/2026 RCKT_US — MSN
Rocket Pharma wins FDA nod for gene therapy (update)
28/03/2026 RCKT_US — MSN
Rocket Pharma wins FDA nod for gene therapy (update)
27/03/2026 RCKT_US — Finimize
Rocket Pharmaceuticals Faces A Make-Or-Break FDA Call On KRESLADI
27/03/2026 RCKT_US — Stocktwits
RCKT Stock Jumps Over 10% Premarket: FDA Approves Its First Gene Therapy For Rare Childhood Immune Disease
27/03/2026 RCKT_US — The Norfolk Daily News
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Página 5 de 7

keyboard_arrow_up